Clinical Trials at Jersey City Medical Center
As of August 2026, 20 paid clinical trials are recruiting at Jersey City Medical Center, located at 355 GRAND STREET, EXECUTIVE OFFICE, JERSEY CITY, NJ 07302-4321, phone (201) 770-3712 in Jersey City, New Jersey. Active studies at this site cover conditions such as Acute Myocardial Infarction, Anatomic Stage II Breast Cancer AJCC v8 and Coronary Artery Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
20 clinical trials at Jersey City Medical Center
·Clear filters·MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Common conditions studied in Jersey City
- Acute Myocardial Infarction (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Coronary Artery Disease (2 active studies)
- Muscle Invasive Bladder Urothelial Carcinoma (2 active studies)
- Obesity (2 active studies)
- Ovarian Carcinoma (2 active studies)
Leading research sponsors in Jersey City
- National Cancer Institute (NCI)
- NRG Oncology
- Rutgers, The State University of New Jersey
- AstraZeneca
- AO Innovation Translation Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Jersey City?
There are approximately 42 recruiting clinical trials in Jersey City, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Jersey City pay participants?
Most recruiting trials in Jersey City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Jersey City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Jersey City?
The most common conditions under active study in Jersey City include Acute Myocardial Infarction (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Coronary Artery Disease (2), Muscle Invasive Bladder Urothelial Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Jersey City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Jersey City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Jersey City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Jersey City?
Recruiting research sites in Jersey City include Jersey City Medical Center, RWJBarnabas Health Jersey City Medical Center, AURORA-2 Clinical Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Jersey City right now?
The largest active categories in Jersey City are Cancer & tumors (20), Cardiovascular (5), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Jersey City Medical Center?
Jersey City Medical Center is located at 355 GRAND STREET, EXECUTIVE OFFICE, JERSEY CITY, NJ 07302-4321. Use the Google Maps link in the intro above to get directions.
How do I contact Jersey City Medical Center?
You can reach Jersey City Medical Center by phone at (201) 770-3712. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.